Growing roles for the mTOR pathway

Current Opinion in Cell Biology

Volumn 17, Issue 6, 2005, Pages 596-603

  Sarbassov, Dos D ^a   Ali, Siraj M ^a   Sabatini, David M ^a  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AP 23573; EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; RAPAMYCIN DERIVATIVE; TEMSIROLIMUS; UNCLASSIFIED DRUG;

AUTOPHAGY; BIOGENESIS; CELL GROWTH; CELL PROLIFERATION; GROWTH REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; RNA TRANSLATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; DISEASE; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 27544500981     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2005.09.009     Document Type: Review

References (86)

1. C. Vezina, A. Kudelski, and S.N. Sehgal Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle J Antibiot (Tokyo) 28 1975 721 726
2. R. Cafferkey, P.R. Young, M.M. McLaughlin, D.J. Bergsma, Y. Koltin, G.M. Sathe, L. Faucette, W.K. Eng, R.K. Johnson, and G.P. Livi Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity Mol Cell Biol 13 1993 6012 6023
3. J. Kunz, R. Henriquez, U. Schneider, M. Deuter-Reinhard, N.R. Movva, and M.N. Hall Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression Cell 73 1993 585 596
4. D.M. Sabatini, H. Erdjument-Bromage, M. Lui, P. Tempst, and S.H. Snyder RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs Cell 78 1994 35 43
5. E.J. Brown, M.W. Albers, T.B. Shin, K. Ichikawa, C.T. Keith, W.S. Lane, and S.L. Schreiber A mammalian protein targeted by G1-arresting rapamycin-receptor complex Nature 369 1994 756 758
6. C.J. Sabers, M.M. Martin, G.J. Brunn, J.M. Williams, F.J. Dumont, G. Wiederrecht, and R.T. Abraham Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells J Biol Chem 270 1995 815 822
7. D.H. Kim, D. Sarbassov, S.M. Ali, R.R. Latek, K.V. Guntur, H. Erdjument-Bromage, P. Tempst, and D.M. Sabatini GβL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR Mol Cell 11 2003 895 904
8. D.-H. Kim, D.D. Sarbassov, S.M. Ali, J.E. King, R.R. Latek, H. Erdjument-Bromage, P. Tempst, and D.M. Sabatini mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery Cell 110 2002 163 175
9. K. Hara, Y. Maruki, X. Long, K. Yoshino, N. Oshiro, S. Hidayat, C. Tokunaga, J. Avruch, and K. Yonezawa Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action Cell 110 2002 177 189
10. R. Loewith, E. Jacinto, S. Wullschleger, A. Lorberg, J.L. Crespo, D. Bonenfant, W. Oppliger, P. Jenoe, and M.N. Hall Two TOR complexes, only one of which is rapamycin-sensitive, have distinct roles in cell growth control Mol Cell 10 2002 457 468
11. •] identified rictor through its sequence similarity to yeast AVO3 and renamed it mAVO3.
12. •].
13. J.D. Richter, and N. Sonenberg Regulation of cap-dependent translation by eIF4E inhibitory proteins Nature 433 2005 477 480
14. K.M. Hannan, Y. Brandenburger, A. Jenkins, K. Sharkey, A. Cavanaugh, L. Rothblum, T. Moss, G. Poortinga, G.A. McArthur, and R.B. Pearson mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF Mol Cell Biol 23 2003 8862 8877
15. T. Peng, T.R. Golub, and D.M. Sabatini The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation Mol Cell Biol 22 2002 5575 5584
16. A.J. Meijer, and P. Codogno Regulation and role of autophagy in mammalian cells Int J Biochem Cell Biol 36 2004 2445 2462
17. D.E. Martin, A. Soulard, and M.N. Hall TOR regulates ribosomal protein gene expression via PKA and the Forkhead transcription factor FHL1 Cell 119 2004 969 979
18. J. Chung, C.J. Kuo, G.R. Crabtree, and J. Blenis Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kD S6 protein kinases Cell 69 1992 1227 1236
19. C.J. Kuo, J. Chung, D.F. Fiorentino, W.M. Flanagan, J. Blenis, and G.R. Crabtree Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase Nature 358 1992 70 73
20. D.J. Price, J.R. Grove, V. Calvo, J. Avruch, and B.E. Bierer Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase Science 257 1992 973 977
21. P.E. Burnett, R.K. Barrow, N.A. Cohen, S.H. Snyder, and D.M. Sabatini RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1 Proc Natl Acad Sci USA 95 1998 1432 1437
22. -/- mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway Mol Cell Biol 24 2004 3112 3124
23. J. Montagne, M.J. Stewart, H. Stocker, E. Hafen, S.C. Kozma, and G. Thomas Drosophila S6 kinase: a regulator of cell size Science 285 1999 2126 2129
24. D.C. Fingar, S. Salama, C. Tsou, E. Harlow, and J. Blenis Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E Genes Dev 16 2002 1472 1487
25. S. Oldham, J. Montagne, T. Radimerski, G. Thomas, and E. Hafen Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin Genes Dev 14 2000 2689 2694
26. H. Zhang, J.P. Stallock, J.C. Ng, C. Reinhard, and T.P. Neufeld Regulation of cellular growth by the Drosophila target of rapamycin dTOR Genes Dev 14 2000 2712 2724
27. -/- skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control Nat Cell Biol 7 2005 286 294 S6K1, but not S6K2, is the main regulator of skeletal muscle cell size downstream of mTOR so that rapamycin no longer reduces the size of muscle cells null for S6K1. S6K1 does not mediate the anti-proliferative effects of rapamycin.
28. S.C. Bodine, T.N. Stitt, M. Gonzalez, W.O. Kline, G.L. Stover, R. Bauerlein, E. Zlotchenko, A. Scrimgeour, J.C. Lawrence, and D.J. Glass Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo Nat Cell Biol 3 2001 1014 1019
29. C. Rommel, S.C. Bodine, B.A. Clarke, R. Rossman, L. Nunez, T.N. Stitt, G.D. Yancopoulos, and D.J. Glass Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways Nat Cell Biol 3 2001 1009 1013
30. I.H. Park, and J. Chen MTOR signaling is required for a late-stage fusion process during skeletal myotube maturation J Biol Chem 280 2005 32009 32017
31. M. Stolovich, H. Tang, E. Hornstein, G. Levy, R. Cohen, S.S. Bae, M.J. Birnbaum, and O. Meyuhas Transduction of growth or mitogenic signals into translational activation of TOP mRNAs is fully reliant on the phosphatidylinositol 3-kinase-mediated pathway but requires neither S6K1 nor rpS6 phosphorylation Mol Cell Biol 22 2002 8101 8113
32. X. Wang, W. Li, M. Williams, N. Terada, D.R. Alessi, and C.G. Proud Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase EMBO J 20 2001 4370 4379
33. B. Raught, F. Peiretti, A.C. Gingras, M. Livingstone, D. Shahbazian, G.L. Mayeur, R.D. Polakiewicz, N. Sonenberg, and J.W. Hershey Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases EMBO J 23 2004 1761 1769
34. C.J. Richardson, M. Broenstrup, D.C. Fingar, K. Julich, B.A. Ballif, S. Gygi, and J. Blenis SKAR is a specific target of S6 kinase 1 in cell growth control Curr Biol 14 2004 1540 1549
35. S.S. Schalm, D.C. Fingar, D.M. Sabatini, and J. Blenis TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function Curr Biol 13 2003 797 806
36. S.S. Schalm, and J. Blenis Identification of a conserved motif required for mTOR signaling Curr Biol 12 2002 632 639
37. H. Nojima, C. Tokunaga, S. Eguchi, N. Oshiro, S. Hidayat, K. Yoshino, K. Hara, N. Tanaka, J. Avruch, and K. Yonezawa The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif J Biol Chem 278 2003 15461 15464
38. J. Colombani, S. Raisin, S. Pantalacci, T. Radimerski, J. Montagne, and P. Leopold A nutrient sensor mechanism controls Drosophila growth Cell 114 2003 739 749
39. S.M. Ali, and D.M. Sabatini Structure of S6 kinase 1 determines whether raptor-mTOR or rictor-mTOR phosphorylates its hydrophobic motif site J Biol Chem 280 2005 19445 19448
40. •] show that rictor in Dictyostelium is needed for activation of Akt/PKB.
41. ••].
42. K.U. Birkenkamp, and P.J. Coffer Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors Biochem Soc Trans 31 2003 292 297
43. B.P. Zhou, Y. Liao, W. Xia, Y. Zou, B. Spohn, and M.C. Hung HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation Nat Cell Biol 3 2001 973 982
44. Y. Ogawara, S. Kishishita, T. Obata, Y. Isazawa, T. Suzuki, K. Tanaka, N. Masuyama, and Y. Gotoh Akt enhances Mdm2-mediated ubiquitination and degradation of p53 J Biol Chem 277 2002 21843 21850
45. S.B. Helliwell, A. Schmidt, Y. Ohya, and M.N. Hall The Rho1 effector Pkc1, but not Bni1, mediates signalling from Tor2 to the actin cytoskeleton Curr Biol 8 1998 1211 1214
46. K.E. Hentges, B. Sirry, A.C. Gingeras, D. Sarbassov, N. Sonenberg, D. Sabatini, and A.S. Peterson FRAP/mTOR is required for proliferation and patterning during embryonic development in the mouse Proc Natl Acad Sci USA 98 2001 13796 13801
47. •] show that mTOR null mice die during early embryogenesis and at an earlier time point than the 'flat-top' mTOR mutant mice described in [46].
48. •].
49. N. Tapon, N. Ito, B.J. Dickson, J.E. Treisman, and I.K. Hariharan The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation Cell 105 2001 345 355
50. X. Gao, Y. Zhang, P. Arrazola, O. Hino, T. Kobayashi, R.S. Yeung, B. Ru, and D. Pan Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling Nat Cell Biol 4 2002 699 704
51. L.J. Saucedo, X. Gao, D.A. Chiarelli, L. Li, D. Pan, and B.A. Edgar Rheb promotes cell growth as a component of the insulin/TOR signalling network Nat Cell Biol 5 2003 566 571
52. H. Stocker, T. Radimerski, B. Schindelholz, F. Wittwer, P. Belawat, P. Daram, S. Breuer, G. Thomas, and E. Hafen Rheb is an essential regulator of S6K in controlling cell growth in Drosophila Nat Cell Biol 5 2003 559 565
53. Y. Zhang, X. Gao, L.J. Saucedo, B. Ru, B.A. Edgar, and D. Pan Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins Nat Cell Biol 5 2003 578 581
54. A.R. Tee, B.D. Manning, P.P. Roux, L.C. Cantley, and J. Blenis Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb Curr Biol 13 2003 1259 1268
55. A. Garami, F.J. Zwartkruis, T. Nobukuni, M. Joaquin, M. Roccio, H. Stocker, S.C. Kozma, E. Hafen, J.L. Bos, and G. Thomas Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2 Mol Cell 11 2003 1457 1466
56. X. Long, Y. Lin, S. Ortiz-Vega, K. Yonezawa, and J. Avruch Rheb binds and regulates the mTOR kinase Curr Biol 15 2005 702 713
57. K. Inoki, T. Zhu, and K.L. Guan TSC2 mediates cellular energy response to control cell growth and survival Cell 115 2003 577 590
58. •] describe novel Drosophila and mammalian proteins, respectively, that operate through TSC1/2 to regulate oxygen sensing by the mTOR pathway. [ 60,61 ] describe similar results in mammalian cells.
59. •].
60. A. Sofer, K. Lei, C.M. Johannessen, and L.W. Ellisen Regulation of mTOR and cell growth in response to energy stress by REDD1 Mol Cell Biol 25 2005 5834 5845
61. R. Schwarzer, D. Tondera, W. Arnold, K. Giese, A. Klippel, and J. Kaufmann REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase Oncogene 24 2005 1138 1149
62. K. Inoki, Y. Li, T. Zhu, J. Wu, and K.L. Guan TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling Nat Cell Biol 4 2002 648 657
63. C.J. Potter, L.G. Pedraza, and T. Xu Akt regulates growth by directly phosphorylating Tsc2 Nat Cell Biol 4 2002 658 665
64. B.D. Manning, A.R. Tee, M.N. Logsdon, J. Blenis, and L.C. Cantley Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway Mol Cell 10 2002 151 162
65. P.P. Roux, B.A. Ballif, R. Anjum, S.P. Gygi, and J. Blenis Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase Proc Natl Acad Sci USA 101 2004 13489 13494
66. A.R. Tee, R. Anjum, and J. Blenis Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin J Biol Chem 278 2003 37288 37296
67. L. Ma, Z. Chen, H. Erdjument-Bromage, P. Tempst, and P.P. Pandolfi Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis Cell 121 2005 179 193
68. A. Hahn-Windgassen, V. Nogueira, C.C. Chen, J.E. Skeen, N. Sonenberg, and N. Hay Akt activates mTOR by regulating cellular ATP and AMPK activity J Biol Chem 2005
69. A.L. Edinger, and C.B. Thompson Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake Mol Biol Cell 13 2002 2276 2288
70. X. Long, S. Ortiz-Vega, Y. Lin, and J. Avruch Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency J Biol Chem 280 2005 23433 23436
71. A. Takano, I. Usui, T. Haruta, J. Kawahara, T. Uno, M. Iwata, and M. Kobayashi Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin Mol Cell Biol 21 2001 5050 5062
72. F. Tremblay, and A. Marette Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells J Biol Chem 276 2001 38052 38060
73. T. Haruta, T. Uno, J. Kawahara, A. Takano, K. Egawa, P.M. Sharma, J.M. Olefsky, and M. Kobayashi A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1 Mol Endocrinol 14 2000 783 794
74. L.S. Harrington, G.M. Findlay, A. Gray, T. Tolkacheva, S. Wigfield, H. Rebholz, J. Barnett, N.R. Leslie, S. Cheng, and P.R. Shepherd The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins J Cell Biol 166 2004 213 223
75. C.J. Carlson, M.F. White, and C.M. Rondinone Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylation Biochem Biophys Res Commun 316 2004 533 539
76. •] show that S6K1 instead of Akt/PKB may phosphorylate S2448 of mTOR. This work has implications for the use of phospho-S2448 mTOR as a histological marker for Akt/PKB activity in tumors.
77. •].
78. C. Di Mario, H. Griffiths, B. O'Rourke, and S. Kaddoura The impact of sirolimus eluting stents in interventional cardiology Int J Cardiol 95 2004 117 121
79. S.C. Chueh, and B.D. Kahan Clinical application of sirolimus in renal transplantation: an update Transpl Int 18 2005 261 277
80. T. Radimerski, J. Montagne, M. Hemmings-Mieszczak, and G. Thomas Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling Genes Dev 16 2002 2627 2632
81. R.J. Shaw, N. Bardeesy, B.D. Manning, L. Lopez, M. Kosmatka, R.A. DePinho, and L.C. Cantley The LKB1 tumor suppressor negatively regulates mTOR signaling Cancer Cell 6 2004 91 99
82. M.N. Corradetti, K. Inoki, N. Bardeesy, R.A. DePinho, and K.L. Guan Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome Genes Dev 18 2004 1533 1538
83. M.S. Neshat, I.K. Mellinghoff, C. Tran, B. Stiles, G. Thomas, R. Petersen, P. Frost, J.J. Gibbons, H. Wu, and C.L. Sawyers Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR Proc Natl Acad Sci USA 98 2001 10314 10319
84. +/- mice Proc Natl Acad Sci USA 98 2001 10320 10325
85. •] provide the first in vivo demonstration in mice of the suppressive effect of the feedback loop from raptor-mTOR to the PI3K/Akt pathway on the aggressiveness of tumors formed in a model of tuberous sclerosis complex.
86. •].